CMB305: FDA feedback related to pivotal path by Q4 2017 (Immune Design) - Sep 7, 2017 - Corporate Overview: Initiation of pivotal monotherapy trial in STS in 2018; 1-year data from pivotal monotherapy trial in STS in H1 2019
Clinical data • FDA event • New trial • Oncology • Sarcoma • Solid Tumor
|